Published on 22 Feb 2024 on GuruFocus.com via Yahoo Finance
Insider Sell: Vaxcyte Inc CFO Andrew Guggenhime Disposes of 8,000 Shares
Andrew Guggenhime, the President and CFO of Vaxcyte Inc (NASDAQ:PCVX), has sold 8,000 shares of the company on February 20, 2024, according to a recent SEC Filing. Vaxcyte Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative vaccine candidates. The company aims to improve global health through the power of its vaccine technologies.
Warning! GuruFocus has detected 3 Warning Sign with PCVX.
The insider's transaction history indicates that over the past year, Andrew Guggenhime has sold a total of 54,000 shares and has not made any purchases of the company's stock.